Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)

Clinical trial NCT04629105 · UNKNOWN

Trial details

NCT number: NCT04629105
Sponsor: Longeveron Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

ARDS, Human Covid19

Start date: 2020-07-24
Primary completion: 2024-06-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.